Milk Powder Synthetic, Low Calcium Oral Powder
Recommended MetabolicRestrictedNot applicable line
Dietary management of hypercalcaemia in patients under 4 years of age.
1
Submissions
1 resub
2024–24
On the record
—
ICER range
Not modelled
Cost basis
Access path
- Jul 2024Recommended
- PBS listing · Restricted
RecommendedDeferredNot recommended
From the public summary
PBAC outcome
6.1 The PBAC recommended that the new formulation of milk powder synthetic low calcium oral powder 400 g (Locasol®) continue to be listed on the PBS under the existing conditions as the current formulation.PSD · Jul 2024
6.2 The PBAC noted and supported the NPWP’s advice that the new formulation is expected to provide non-inferior clinical benefit and safety compared to the current formulation for the dietary management of hypercalcaemia.PSD · Jul 2024
Cost-effectiveness
No economic analysis performed; this is a formulation change submission with no change to price or listing conditions.
Decision context
PopulationInfants and children under 4 years of age requiring dietary management of hypercalcaemia.
Submission history
| Decided | Outcome | Comparator | ICER | Evidence |
|---|---|---|---|---|
| Jul 2024 | Recommended | — | — | Other |
Similar precedents
Milk Powder Synthetic Low Calcium98%High Fat Formula With Vitamins, Minerals And Trace Elements And Low In Protein And Carbohydrate61%Triglycerides Medium Chain And Long Chain With Glucose Polymer59%Sodium Zirconium Cyclosilicate59%Milk Powder - Lactose Intolerance Formula59%Amino Acid Synthetic Formula Supplemented With Long Chain Polyunsaturated Fatty Acids; Amino Acid Formula Supplemented With Prebiotics, Probiotics And Long Chain Polyunsaturated Fatty Acids59%Medium Chain Triglycerides; Protein Formula With Carbohydrate, Fat, Vitamins And Minerals58%Amino Acid Synthetic Formula57%